Metsera, Inc. , a clinical-stage biotechnology company, develops injectable and oral nutrient stimulated hormone analog peptides to treat obesity, overweight, and related diseases.
Metsera stock last closed at $29.38, down 15.04% from the previous day, and has decreased N/A in one year. It has underperformed other stocks in the Biotechnology industry by N/A percentage points. Metsera stock is currently +138.86% from its 52-week low of $12.30, and -22.66% from its 52-week high of $37.99.
As of Jun 13, 2025, there are 105.06M shares of MTSR outstanding. The market cap of MTSR is $3.09B. In the past 24 hours, 808,000 MTSR shares were traded.
You need a brokerage account in order to access the NASDAQ market and buy MTSR stock.
Based on our experience, eToro is the best stock brokerage. eToro gives you:
Get $10 towards your purchase of stock by opening an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've selected the right brokerage, it's time to fill out some personal details so you are able to buy MTSR stock today.
Now that you have created your account on a good online stock trading app, your next step is to transfer the money for your investment:
Watch the tutorial below for more details transferring funds into your brokerage account.
After you have identified the best place to buy Metsera stock, it's critical to research their stock prior to buying, so you truly comprehend the risk as well as the opportunity.
WallStreetZen was designed to help everyday investors do better fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on MTSR's stock page.
Investors use a variety of different financial metrics, analyses, models, and charts to gauge MTSR's true value.
Using relative valuations measures:
You can access additional valuation research on MTSR's stock here.
Out of 3 Equities analysts who give recommendations on MTSR, the consensus analyst rating on MTSR is a Strong Buy
Please keep in mind that analyst ratings are not recommendations, nor are they investment advice.
You can dive deeper into what analysts are projecting on the Metsera stock forecast page.
Over the last year, executives and large shareholders at MTSR have bought more shares than they have sold.
Arch Venture Partners XII LLC, 10% Owner of MTSR, was the latest MTSR insider to buy. They bought $25,780,032.00 worth of MTSR shares on Feb 3, 2025.
Research more about who owns MTSR stock here.
No, Metsera doesn't provide an income stream by paying out dividends.
One of the reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other investors have to say.
There are two primary types of orders:
Click the Open Trade button and your broker will execute the order.
If you need more assistance buying stocks on eToro, watch the helpful video below:
Now that you own some shares in MTSR, you'll want to stay up-to-date on your shares.
Create a watchlist to track the most important metrics related to your MTSR stock.
To reiterate, here are the 6 steps for buying Metsera stock:
If you are looking for a brokerage account, eToro is our favorite option.
Get Started with eToro TodayIf you would like to get notifications regarding your investment in Metsera, create a watchlist today.